Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Acreage Holdings:

Should you invest in Acreage Holdings Stock? Recommendation: Keep Reading

Acreage Holdings: Featured Cannabis StockAcreage Holdings, Inc. ACRGF (OTC), ACRG (CNSX) owns and operates cannabis licenses and assets in the U.S. They are an MSO with a tentative agreement with Canopy Growth to be acquired when cannabis becomes federally legal in the US. They focus on the cultivation, processing, and distribution of cannabis. Why is Acreage Holdings a Featured Cannabis Stock? Read on to see why.

Acreage Holdings: Company Profile

HQ: New York, NY, USA
Founded: 2014 (High St. Partners)
Facilities: 20 states
Symbol: ACRGF (OTC) & ACRG (CNSX)

Acreage Holdings: Strong Focus

Acreage Holdings is a New York-based investment company (formerly High Street Partners) that is officially domiciled in Canada – since it went public there. Through acquisition, it has built itself into leading vertically-integrated multi-state U.S. cannabis operator (MSO). It owns or has operating agreements in place for licenses in 20 states, including 87 dispensaries and 22 cultivation and processing sites. Its Board of Directors includes former Canadian Prime Minister Brian Mulroney and former Speaker of the U.S. House of Representatives, John Boehner.

As investors, Acreage’s strategy to acquire as many licenses as possible has paid off: Canopy Growth, (now the world’s largest cannabis company by market cap) which is currently prevented from operating in the US until the US changes its cannabis laws, recently bought the right to buy Acreage when the US laws change. The deal involves a $300 million upfront payment and a future payment (when the deal gets done) worth about $3.4 billion in Canopy shares today but could amount to much more (or less) in the future if Canopy shares rise (or fall).

Acreage Holdings: Strong Size

Market Cap: US $185.6 mil
Enterprise Value: US $188.95 mil
Number of employees: 150

Acreage Holdings: Strong Markets

Primary: USA – 10 Northeast states, 5 mid-western states, 3 on the west coast and Florida
Secondary: Canada
Subsidiaries
Majority Subsidiaries: Acreage Oklahoma, LLC; HSCP CN Holdings ULC; High Street Capital Partners, LLC
Minority interests: NA

Acreage Holdings: Neutral Operations

Cultivation100,000 kgs in 1 million SF of production.

Distribution
Direct sales: N/A
Store networks: Acreage has retail stores called “The Botanist”, founded in 2018.

Acreage has operations in 20 states. They own licenses in 13 states, and in the remaining 7 states, they have operating agreements. In 6 “scalable” states, their operations generate revenue and positive EBITDA. In 3 “developing” states, they have revenue but do not yet have positive EBITDA. In the remaining 11 “emerging” states, they are not yet generating revenue.

In the 6 scalable states, they already have their allotted stores. In their 3 developing states, they can open 5 more stores. In their 11 emerging states, they have as many as 51 stores still to open, requiring substantial capital expenditures. If Canopy succeeds in buying Acreage, they will be able to spend from their large cash holdings to open these stores. Acreage also has wholesale operations in 14 states and can open up to 10 more.

Integration/Diversification:
Vertically integrated: Yes
Horizontally diversified: No

Acreage Holdings: Featured Cannabis Stock

Acreage Holdings: Weak Financials

  • Revenue (TTM): $74.1 million
  • Margins: -202%
  • Shares Outstanding (diluted): 146.9 mil
  • EPS (diluted): (1.74)

Acreage Holdings: Strong Management

CEO: Kevin P. Murphy
CFO: Glen S. Leibowitz
COO: Robert J. Daino

Acreage Holdings: Neutral Branding

As this is an investment company that is growing by acquisition, the company information covers the big picture. Acreage does not discuss brands, or production capacity, like most cannabis companies do.

It’s Botanist stores currently carry “Etain”, “Pharmacann” and “Pure Dakota” brand products. It is not clear if the company is developing its own branded products yet.

The company sells many forms of cannabis products through its stores, including cannabis flower, tinctures, vapes, sprays, cartridges, powders, solutions, shatter, wax, and capsules.

Acreage Holdings: Neutral Valuation

  • Current share price: US $2.32
  • Price to Sales: 2.96 (Biopharma industry average = 7.5)
  • EV / Revenue: 3.40
  • 52 week low/high: US $1.47-$20.37
  • Price/Book: 0.41

Acreage Holdings: Strong Financings

The recent deal with Canopy gives Acreage $300 million now. It also allows Acreage to issue up to 58 million Subordinate Voting Shares (SVS, implied value of $1.4 billion), plus up to 5 million more, which would become future Canopy Shares. These give Acreage a strong ability to fund expansion.

Acreage Holdings: High Risks

The risks of investing in any cannabis or hemp company are currently high given the newness of the market. The risks of investing in this company may be somewhat reduced due to Canopy Growth’s investment in buying this company. However, Acreage’s revenue is low and it has no positive income yet.

Acreage Holdings: Neutral Recommendation

Many cannabis companies were built from the ground up by cannabis entrepreneurs struggling in the trenches to learn to grow and produce cannabis.

Acreage Holdings is different. It was started by a Wall Street veteran, Kevin Murphy, and his High Street Partners investment firm. Kevin bought his way onto the Board of a cannabis company in Maine in 2011. From there he learned the investment side of the business and crafted a strategy to acquire a portfolio of cannabis businesses that controlled production and retail licenses in key states.

He now controls Acreage Holdings, a business with operations in 20 states, 300 employees, 26 operating dispensaries, a wholesale business, licenses to operate 85 dispensaries, and quite a few cultivation facilities, some operating and others under development. As an aggregator, not a builder, they are not focused on (and do not publish) how much cannabis they can or will produce.

Murphy’s strategy appears to have paid off handsomely, as Canopy Growth in April 2019 paid Acreage $300 million for the right to buy Acreage in the future when it is legal for Canopy to do. Canopy will then pay the rest, which will likely amount to over $3.5 billion. Canopy is currently forbidden to operate in the US, where cannabis is federally illegal, due to rules of the CSE exchange it trades on. Canopy wants to build its US business quickly, and thus wanted to buy a company with a lot of licenses. It has tons of cash to invest in opening the stores.

By itself (not counting the pending Canopy deal), Acreage has a lot of growth potential but is very highly-priced, with a Price to Sales ratio of 100. This is 20 times more than what we would expect it to be, when compared to a mature industry. With current annual revenue of about $50 million per year, we estimate that the stock is already priced for revenue of about $1 billion.

On this basis, we would not recommend it as a good investment, as it would take them a long time to reach that level.

The Canopy deal does improve its prospects. If Canopy stock maintains its current value, it will pay 25% more for Acreage than it is currently priced at. If Canopy shares climb, it will pay even more. But if Canopy shares decline, it will pay less, or even no premium at all.

Canopy’s confidence is compelling. But since we cannot know what Canopy will eventually pay for Acreage, we cannot say that the stock is a good value now.

Therefore, we recommend watching this stock, but not buying it. If investors can watch and time the development of the legal landscape that will permit Canopy to buy Acreage, AND Canopy’s stock has maintained its value or risen, then this will be a good stock to buy. Of course, the longer an investor waits to make that decision, the less premium will likely be available in the market, as other investors get in first.

Acreage Holdings: Featured Cannabis Stock


About Cannin: Your Marijuana Investment Experts

Acreage Holdings: Featured Cannabis StockCannin is your trusted resource for information about marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. We provide the latest marijuana investment and hemp investment news and analysis. 

Use Cannin as your resource for breaking cannabis and hemp investing news, featured cannabis and hemp company analysis, comprehensive cannabis and hemp stock reports, or get your free trial now and use our Smart Stock Algorithm to take the guesswork out of profiting from the cannabis industry. Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest. Acreage Holdings: Featured Cannabis Stock is blazing a strong path forward in the cannabis industry but will this pot stock survive and thrive?

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

Profit from the best marijuana stocks – we’ll show you how at cannin.com